报道 ,记者 11月 2 2日从国家食品药品监督管理局获悉 ,经过 6个多月的努力 ,我国已基本完成SARS病毒灭活疫苗的临床前研究 ,预计今年 12月底前可进入临床试验。这标志我国SARS疫苗研究已处于国际领先水平。北京科兴生物制品有限公司已向国家食品药品监督管理局正式提出了SARS Reported that on November 22, the reporter learned from the State Food and Drug Administration that after more than six months of hard work, China has basically completed the preclinical study on the SARS virus inactivated vaccine and is expected to enter clinical trials before the end of December this year. This marks the SARS vaccine research in China has reached the international advanced level. Beijing Kexing Biological Products Co., Ltd. has formally submitted to the State Food and Drug Administration SARS